Real-time enrollment status for this spinal muscular atrophy (sma) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:50 AM UTC
| NCT Number | NCT04174157 |
| Recruiting Status | Recruiting |
| Condition | Spinal Muscular Atrophy (SMA) |
| Phase | Clinical Trial |
| Target Enrollment | 700 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | January 31, 2025 (Jan 31, 2025) |
As of July 13, 2026: Clinical trial NCT04174157 is currently recruiting participants. This clinical trial study for spinal muscular atrophy (sma) is actively seeking new participants at 50 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04174157 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04174157 was last updated Jan 31, 2025 (January 31, 2025). HelloStudys verifies this status automatically.